KS79356, a novel kynureninase inhibitor, suppresses triple-negative breast cancer progression by attenuating the TNF-α/NFκB–CD44–Akt signaling axis Maha Alamodi Alghamdi Hemali Deshpande Ashish Kumar Prasanna Rajagopalan Aug 2026 · Medical Oncology · Vol 43 · 0 citations · 45 references Medicine DOI PubMed Semantic Scholar Save View source Cite Copy APA Copied ✓ Copy MLA Copied ✓ Copy BibTeX Copied ✓ Share